Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Pomdoctor Limited - Sponsored ADR (POM : NSDQ)

• Company Description    POMDOCTOR LIMITED is an online medical services platform for chronic diseases principally in China. The Company's operations primarily include internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals and other healthcare participants. POMDOCTOR LIMITED is based in GUANGZHOU, China. Number of Employees: 156

• Price / Volume Information    Yesterday's Closing Price: $6.09 Daily Weekly Monthly 20 Day Moving Average: 3,216,433 shares Shares Outstanding: 101.19 (millions) Market Capitalization: $616.26 (millions) Beta: 52 Week High: $6.43 52 Week Low: $3.47 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 27.67% 27.95% 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL YONGXU INDUSTRIAL PARK NO.19-23 HEJING RD LIWAN DISTRICT - GUANGZHOU,F4 510000 CHN ph: 86-020-6231-2277 fax: - ir@7lk.com http://www.7lk.com

• General Corporate Information    Officers Zhenyang Shi - Chief Executive Officer and Chairman Li Xu - Chief Financial Officer Guoji Luo - Vice President Yuanyuan Jing - Director Wenqing Bao - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 73181R108 SIC: 5900 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 101.19 Most Recent Split Date: (:1) Beta: Market Capitalization: $616.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/25 - - 06/30/25 - - 03/31/25 - - ROA 09/30/25 - - 06/30/25 - - 03/31/25 - - Current Ratio 09/30/25 - - 06/30/25 - - 03/31/25 - - Quick Ratio 09/30/25 - - 06/30/25 - - 03/31/25 - - Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Book Value 09/30/25 - - 06/30/25 - - 03/31/25 - - Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Capital 09/30/25 - - 06/30/25 - - 03/31/25 - -

Powered by Zacks Investment Research ©